Stock Update: AbbVie Inc (NYSE:ABBV) – AbbVie to Present at the Bank of America Merrill Lynch 2016 Global Health Care Conference

[PR Newswire] – NORTH CHICAGO, Ill., April 29, 2016 /PRNewswire/ — AbbVie (ABBV) will participate in the Bank of America Merrill Lynch 2016 Global Health Care Conference on Thursday, May 12, 2016. Bill Chase, executive vice president and chief financial officer, will participate in a question and answer session at 1:20 p.m. Central time. A live audio webcast of the presentation will be accessible through AbbVie’s Investor Relations website at www.abbvieinvestor.com. Read more on this. AbbVie Inc. (ABBV) , with a current value of $98.12B, started the session at $61.03. During today’s session, ABBV traded between $60.48 to $61.18 and has traded between $45.45 and $71.60 over the past year. ABBV shares are currently priced at 12.44x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s -6.99x earnings multiple. And for dividend hunters, the company pays shareholders $2.28 per share annually in dividends, yielding 3.74%. In a review of the consensus earnings estimate this quarter, 16 sell-side analysts are looking at $1.21 per share, which would be $0.13 better than the year-ago quarter and a $0.02 sequential decrease. Furthermore, our analysis shows the full-year EPS estimate to be $4.92, which would be a $0.63 better when compared to the last year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $6.29 Billion. If reported, that would be a 14.78% increase over the year-ago quarter. More recently, Societe Generale Initiated ABBV at Sell (Apr 6, 2016). Previously, Deutsche Bank Initiated ABBV at to Hold. Investors should keep in mind is that the average price target is $70.00, which is 14.70% above where the stock opened this morning. See more in (NYSE:ABBV) Similar Articles: Market Update: AbbVie Inc (NYSE:ABBV) – AbbVie to Host First-Quarter Earnings Conference Call Market Update: AbbVie Inc (NYSE:ABBV) – AbbVie and Boehringer Ingelheim announce global collaboration on promising immunology compounds Market Update (NYSE:ABBV): AbbVie to Present at Cowen and Company 36th Annual Health Care Conference
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.